Levalbuterol has not been established to have therapeutic advantage over racemic albuterol.
Asmus
Michael J
MJ
Hendeles
Leslie
L
Weinberger
Miles
M
Ahrens
Richard C
RC
Bisgaard
Hans
H
Lötvall
Jan
J
O'Byrne
Paul M
PM
Cockcroft
Donald W
DW
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000420:Albuterol / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D003257:Consumer Product Safety; D004305:Dose-Response Relationship, Drug; D005541:Forced Expiratory Volume; D006801:Humans
D000318:Adrenergic beta-Agonists; D018927:Anti-Asthmatic Agents; D000420:Albuterol